Sharp Therapeutics

Sharp Therapeutics Current Ratio

Current Ratio of Sharp Therapeutics (SHRX.V) as of Nov 3, 2026.

Current Ratio

0.00

Last updated:

Current Ratio of Sharp Therapeutics is 2025 0.00 . Current Ratio of Sharp Therapeutics was 2024 0.00 . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sharp Therapeutics Stock analysis

What does Sharp Therapeutics do? EVP Capital Inc is a Canada-based capital pool company headquartered in Toronto, Ontario, that identifies and evaluates assets or businesses for a qualifying transaction. The company has not commenced operations and has generated no revenue, focusing solely on potential acquisitions. It operates as a capital pool company without any current business activities or revenue streams. The company's business model centers on identifying and evaluating potential assets or businesses to complete a qualifying transaction, but it has not yet engaged in any operational activities or generated revenue. As a capital pool company, it serves as a vehicle for future acquisitions without any current revenue-generating products or services. EVP Capital Inc's primary focus is on the identification and evaluation of assets or businesses with the intent to complete a qualifying transaction. The company remains in a pre-revenue stage, having not commenced operations or generated any revenue, and operates as a capital pool company with no current business activities. Sharp Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sharp Therapeutics stock

On Eulerpool you can find the complete historical development of Current Ratio Sharp Therapeutics since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Sharp Therapeutics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Sharp Therapeutics

All Key Metrics — Sharp Therapeutics